ClotTriever Outcomes (CLOUT) Registry (CLOUT)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03575364|
Recruitment Status : Active, not recruiting
First Posted : July 2, 2018
Last Update Posted : January 20, 2023
|Condition or disease||Intervention/treatment|
|Deep Vein Thrombosis Leg DVT Chronic DVT of Lower Extremity Acute DVT of Lower Extremity||Device: ClotTriever|
|Study Type :||Observational [Patient Registry]|
|Actual Enrollment :||500 participants|
|Target Follow-Up Duration:||2 Years|
|Official Title:||ClotTriever Outcomes (CLOUT) Registry|
|Actual Study Start Date :||September 1, 2018|
|Actual Primary Completion Date :||March 25, 2022|
|Estimated Study Completion Date :||March 31, 2024|
Patients with unilateral acute or subacute DVT of less than 6 weeks' duration.
Patients with proximal lower extremity DVT.
- Composite of Major Adverse Events (MAEs) [ Time Frame: 30 days ]All-cause mortality, major bleeding, symptomatic PE, or rethrombosis of target venous segment
- Technical Success [ Time Frame: Index procedure ]Complete or near complete (75% or greater) removal of venous thrombus from the target venous segment
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03575364